BTS Returns To Rule LIVE75, Crowned Hot Shot & Heavy Hitter

Courtesy Big Hit Entertainment
plays MetLife Stadium May 18-19.

BTS powers its way onto LIVE75 with a HOT SHOT debut at No. 1 based on the top sold-ticket average as well as the HEAVY HITTER designation for the highest gross average of the week at $4,036,341. The data comes from a three-show run Oct. 26-27 and 29 at Jamsil Olympic Stadium in the septet’s hometown of Seoul, marking the finale of the group’s “Love Yourself: Speak Yourself” tour. Overall, the world trek included 20 stadium performances in seven countries.  

Total attendance for the event reached 129,268 – the highest since the tour’s May 4 launch at the Rose Bowl in Pasadena, Calif. An extension of the group’s “Love Yourself” trek that played stadiums and arenas from August 2018 through April of this year, the tour grossed more than $115 million from 976,283 sold seats.

Joining BTS as touring artists making a new entrance in this issue are Elton John, Tool and Dead & Company who all rank in the Top 10 based on sales from arena dates on their ongoing jaunts. A bit further down the chart with a Top 25 debut are Fantasia and Wilco, both ranking with sales totals from either mid-sized arenas or theaters. At No. 24, Fantasia scores with sales from five venues on her “The Sketchbook Tour” that kicked off stateside in October. With Robin Thicke, Tank, and The Bonfyre onboard as openers, the former “American Idol” champion will remain on the road into December.

Wilco lands at No. 25 with ticket totals reported from theater dates in three cities including the Chicago-based band’s top draw of the three, an Oct. 12 sellout at Radio City Music Hall in New York with 5,952 in the house.